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Health in all policiesThe assessment of health risks of policies is an inevitable, although challenging prerequisite for the inclusion
of health considerations in political decision making. The aim of our project was to develop a so far missing
methodological guide for the assessment of the complex impact structure of policies. The guide was developed
in a consensual way based on experiences gathered during the assessment of specific national policies selected
by the partners of an EU project. Methodological considerations were discussed and summarized in workshops
and pilot tested on the EU Health Strategy for finalization. The combined tool, which includes a textual guidance
and a checklist, follows the top-down approach, that is, it guides the analysis of causal chains from the policy
through related health determinants and risk factors to health outcomes. The tool discusses the most important
practical issues of assessment by impact level. It emphasises the transparent identification and prioritisation of
factors, the consideration of the feasibility of exposure and outcome assessment with special focus on quantifica-
tion. The developed guide provides useful methodological instructions for the comprehensive assessment of
health risks of policies that can be effectively used in the health impact assessment of policy proposals.
© 2014 Elsevier Inc. All rights reserved.Introduction
Health is determined by awide range of factors, most of them falling
outside the scope of the health sector. Because health determinantsand Society, Faculty of Health
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(I. Zurlyte),represent virtually all areas of life, a political decision very likely affects
health. The aim of conducting healthy public policy appears as an action
area in the Ottawa Charter for Health Promotion followed by the
Adelaide Recommendations on Healthy Public Policy. Both documents
emphasise the need of political commitment for promoting health at
the population level (WHO, 1986, 1988). The inclusion of human health
and well-being as one of the main principles of policy development in
all sectors is the concept of Health in all policies (Ståhl et al., 2006;
WHO and Government of South Australia, 2010). However, it is not an
easy task since evidence based consideration of health issues is not
readily accommodated in the policy process of non-health sectors
even in areas closely related to health, though it can be substantially
facilitated by appropriate methodology.
Health impact assessment (HIA) is a methodological framework
for predicting health impact of policy proposals and consequently to as-
sist decision makers (WHO European Centre for Health Policy, 1999),
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some (Ádám, 2012; Davenport et al., 2006; Mannheimer et al., 2007).
The standard HIA methodology consisting of screening, scoping, risk
appraisal, decisionmaking,monitoring and evaluationworkswell onpro-
jects and programmes where well-defined hazards are identified. The
involvement of all stakeholders, combination of both qualitative and
quantitative approaches and use of risk assessmentmethodology provide
sound tool to quantify the risks related to hazards. If HIA is applied to pol-
icies a similar risk assessment method which would allow identification
and quantification of risks is missing. Methods exist to quantify health
effects in the risk factor-health outcome relation (Lhachimi et al., 2010;
Lhachimi et al, 2012; Manuel et al., 2012; Steenland and Armstrong,
2006), especially the effects of environmental factors acting in a single
causal pathway (Basham, 2001; McCarthy et al., 2002; Mesa-Frias et al.,
2013; Utley et al., 2003). A concise, applicable guide that aids the impact
assessment of the complex causal web of policies including social deter-
minants of health is, however, not yet available.
The recognition of this deficiency in knowledge and methodology
for conducting risk assessment on policy health effect led to the launch
of the Risk Assessment from Policy to Impact Dimension (RAPID)
2009–2012 EU-funded project (RAPID, 2013). It had the primary aim
to develop a methodological guidance for the assessment of health
risks related to policies that analyse the “full chain” of causal pathways
from policy level through health determinants and risk factors to health
outcomes in an integrated manner. This article introduces the product
of a series of methodological findings that provide a useful tool either
for the HIA community or for those engaged with the assessment of
policies, enabling them to effectively assist the political decision-
making process regardless of the level and sector of the policy proposal.
Methods
The guidance for the top-down approach of assessing health risks of
policies in an integrated manner was elaborated in a consensual way in
the RAPID project. Ten partners from universities and national public
health institutions of nine EU countries participated in the work. Each
project partner selected a specific national policy and carried out its
assessment. They could freely decide on the application of adequate
methods and national and international information sources, only the
main steps of the assessment were determined in advance. The assess-
ment meant to analyse the policy and to describe all wider, including
socio-economic, determinants of health influenced by the policy. Risk
factors linked to these health determinants and health outcomes related
to selected risk factors were finally identified and assessed. A strong
focus of the project was to include quantitative risk assessment tech-
niques in the analysis. The guidance was formulated with recommenda-
tions on various aspects of conducting quantitative assessment, like
information need and feasibility, integration of quantitative and qualita-
tive assessment elements in specified pathways, evaluation of horizontal
interactions between elements of the same impact level, and characteri-
zation of uncertainty.
The case studies provided the basic input for the development of the
guidance. The methodological findings, experiences and considerations
that were found useful in the preparation of the case studies were
presented and discussed on several work meetings of the project and
the most expedient elements of the consensual methodology were
summarized. After the consensus discussion the developed tool was cir-
culated for final comments and approved as a working version. The first
version of the agreed guidancewas used to analyse selected parts of the
EU Health Strategy (2008–2013). The experiences of the pilot testing
allowed for its further improvement. The tool was then presented on a
series of national workshops that were organised for experts involved
in various risk assessment practices in the participating countries.
The participants were invited from a database of risk assessors that
was constructed in a previous phase of the project. They represented
diverse areas (health, economics, construction, etc.) and organisations(academic, governmental, private). The expert opinion of participants
provided feedback to finalize the guidance as well as opportunity to
distribute it in the professional community of risk assessors as poten-
tial users.
Results
Guidance for the assessment of health risks of policies
Policy
The assessed policy (strategy, programme or regulation) is prefera-
bly of substantial importance from a population health point of view, re-
gardless of the sector and level of its initiation that can be either central,
regional or local government, industry or other organisations. The com-
mission for the conduct of assessment can come from policy makers. If
the tool is applied within an on-going HIA the task can come from the
scoping part of the process; if not used within an HIA then all following
issues need to be considered at the beginning of assessment. In case a
policy is not given at forehand or the policy is too broad that should
be narrowed down, a transparent selection process is important. The
most appropriate way is to have a set of criteria for the pre-selection
of policies that should include the importance of the topic and the
need of policy makers for assistance in the decision-making process. It
is recommended to analyse the pre-selected policies by feasibility issues
like availability of verifiable objectives, definable target group, valid
data and dose–response functions and evidence on influenced health
determinants and risk factors.
After the policy to be assessed is defined, a good understanding of
the policy context is of crucial importance in order to be able to link
the policy to impacts on health and health inequalities: map the impact
structure, prioritise impact pathways and identify where the challenges
come from. At first, problem identification and demand for action
should be described in a concise way. Placing a national policy into
an international context helps to identify the driving forces of policy
making, meanwhile allows for finding similar policies implemented in
other countries the experiences of which can be fruitfully applied then
in the assessment process. It isworth reviewing the history of the policy,
how it developed with time. The understanding of the legal environ-
ment and the relationship between the assessed and other related
policies allows for the consideration of their interactions. The construc-
tion of amap about the policy's context in the national and international
legal environment can be useful. The policy context regarding stake-
holders and interests should be described in order to explain the devel-
opment and main drivers of the policy in an objective manner. Detailed
description of the policy content is needed in order to demonstrate
the main goals of the policy, tools of implementation and methods of
monitoring and evaluation if it is relevant. Force and effect of the legis-
lation should be examined in order to identify target population and
time course of the implementation. A policy can bewell prepared, how-
ever, its implementation rather poor. Tobe able to assess thepredictable
effects of a policy, the feasibility of its measures should also be taken
into account; the complexity of implementation, availability of re-
sources (institutional, human andfinancial) aswell as public acceptance
and compliance should be all considered. A policy that has clear imple-
mentation plan is easier to be assessed for feasibility. The costs involved
in implementation gives a starting point to cost–benefit considerations.
The analysis of different scenarios, including the status quo, can effec-
tively assist the choice between various policy options.
Health determinants
Health determinants are to link policies to the direct risk factors of
health in the assessment process. In thisway, the factors that are consid-
ered as the determinants – or wider determinants, upstream determi-
nants, causes of causes – of health have typically rather qualitative
nature in the assessment process. Determinants of health are defined
by the Health Promotion Glossary of WHO as “the range of personal,
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status of individuals or populations” (WHO, 1998). In some cases, deter-
minants of health might overlap with risk factors and it is difficult to
differentiate them. Using a model that provides a set of health determi-
nants can help to overcome this problem. There are various models
to describe the structure of health determinants; those presenting the
holistic model of health are preferable. The model of Lalonde can be
effectively used (Lalonde, 1974), but other scientifically recognized
models, like that of Dahlgren and Whitehead (1991), or Barton and
Grant (2006) can also be applied.
The ways for identifying policy-influenced health determinants can
vary, therefore the selectionmethod should be transparently described.
It can include extensive literature review, expert opinion or even in-
volvement of stakeholder participation. The key issue in the selection
of influenced health determinants is the availability of evidence for cau-
sality. Two approaches of selection can be distinguished: the broad con-
sideration (not to lose any) and the strict one that prioritises health
determinants. Prioritisation should focus on the strength of evidence
available and feasibility of – favourably quantitative – assessment of
health outcomes through the assessment of changes in the exposure
levels of risk factors. Making decisions on an impact level based on
the anticipatory evaluation of priority and feasibility issues related to
lower levels, e.g. avoiding the selection of a health determinant to
which risk factors and health outcomes cannot be related downstream
in the impact pathway due to lack of evidence for causality, is a benefi-
cial strategy for effective prioritisation. It can be referred to as internal
loops of consideration between the levels of the causal chain. The selec-
tion process also depends on the primary intention of the assessment,
that is, what policy-makers want to use the assessment for. Further-
more, the amount of resources available determines the need for
prioritisation, too.
To conclude, a clear strategy for choosinghealth determinants for as-
sessment is necessary. If selection is to be narrowed down, the way of
prioritising among the various pathways should consider the strength
of available evidence for causality that enables the judgement on the
likelihood of the existence of impact. The other crucial aspect of
prioritisation is the size/importance of the effect (size of population
affected, severity of health effects, costs involved etc.). The formalization
of the prioritisation process by using a systematic approach to assign
values to the elements of causal chains by context-specific aspects of
priority can further increase transparency.
Risk factors
Risk factors are those factors of the impact chain that directly affect
health (proximal factors). Risk factors are defined according to the
Health Promotion Glossary of WHO as “social, economic or biological
status, behaviours or environments which are associated with or
cause increased susceptibility to a specific disease, ill health, or injury”
(WHO, 1998). This definition specifies factors with negative effect on
health. However, one has to be aware that a factor could also be a pro-
tective factor having a positive effect on health. The prevalence or
level of their contact with individuals is referred to as exposure. It is
imperative to make a distinction between the risk factors acting in the
impact chain and the risk factors modifying individual susceptibility.
The latter is to be considered when identifying susceptible subgroups
of the affected population.
To be able to assess the possible health outcomes of the selected
causal pathways, thorough review and enlistment of all influenced
risk factors is indispensable. The assessment should describe the ex-
posed population, the routes of exposure and the exposure pattern in
different population groups. The latter enables specific assessment of ef-
fects on various groups that allows for considering equity issues. The
prioritisation of risk factors is based essentially on the same principles
as that of health determinants. It should take into account the strength
of evidence for causality, reliability of literature source and biological
plausibility, as well as the significance of induced health effects. Thelatter is determined by the size of exposure change attributable to the
policy, size of population affected and severity of related health out-
comes. Since the extent of being exposed to risk factors may be not
only characterized qualitatively but also measured in a quantitative
way, an important consideration of selection for detailed analysis is
the feasibility of numerical explanation. The quantification of exposure
change due to policy implementation is based on the availability of ap-
plicable exposure measures and numerical information on the baseline
level/prevalence of exposure, aswell as on the expected change of expo-
sure related to policy implementation (exposure assessment). The latter
is ideally provided by studies observing the consequences of the intro-
duction of similar policies, or can be based on expert opinion which
usually implies larger uncertainty. The demand for quantification
also depends on the interest of policy-makers and other stakeholders.
Quantitative exposure assessment can provide the basis for the quanti-
fication of health outcomes, therefore availability of valid data and dose/
exposure–response coefficients for health outcome assessment should
already be considered in the selection process of risk factors, making in-
ternal loops of consideration between the levels of the causal chain.
Health outcomes
Health outcomes that are causally related to the identified risk fac-
tors represent the final consequences of impact pathways. They must
be unambiguously defined, since various stages of a causal chain can
be considered as outcomes, like a disease or health states and events re-
lated to a disease. An adequate solution for clarification is the application
of International Classification of Diseases (ICD) codes (see http://www.
who.int/classifications/icd/en/). The evaluation of the importance of
health outcomes should consider the strength of evidence for causality,
as well as the condition's severity (related morbidity, disability and
mortality), reversibility and frequency of its occurrence in the popula-
tion. These features determine the public health importance of the
health outcome.
The affected population has to be clearly identified with special
attention to susceptible subgroups. Considering varying susceptibility
in outcome assessmentmakes the evaluation of policy impact on health
inequalities possible.
Health outcomes can be assessed in a qualitative or, if feasible, in a
quantitative way. Qualitatively the direction of effect can be stated or
the size of effect can be categorically described. However, a critical
issue in the assessment of health outcomes is the possibility of quantifi-
cation. It needs a decision onwhat kind of healthmeasures, i.e. epidemi-
ological frequency measures, to use as input and output data of the
calculation process. In addition, consideration of the availability of valid
baseline frequency data of the health condition and of dose/exposure–
response functions thatmay apply dose–response coefficients or relative
risks is indispensable for the success. Values of frequency measures of
health conditions and of exposures must be available for the affected
population. They usually derive from routine statistics, population-
based registries or from surveys. Availability and validity of data is crucial
in the process and therefore should be clearly described. The result
of quantitative outcome assessment can be expressed in a frequency
measure, like frequency of occurrence, morbidity, hospitalization and
mortality (Example 1), or favourably in a complex measure of disease
burden, like attributable death, potential years of life lost or disability ad-
justed life years (Example 2). The latter is an advantageous choice for ex-
pressing results of a risk assessment in a quantitative way, since it is a
complexmeasure of disease burden combining effect on bothmorbidity
and mortality. The cost-benefit analysis of policy introduction may also
become possible based on the numerical expression of health outcomes.
Example 1. The case study on the housing program of North Rhine-
Westphalia assessed how the provision of barrier-free homes in the
region would affect the incidence of falls, consequent hip fracture
and death in the elderly population. The quantitative assessment was
based on population statistics and information from the literature and
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deaths due to hip fractures that could have been avoided in the year
2009, if all homes of people aged 65 years and older in the region
were barrier-free (Guliš et al., 2014).
Example 2. The case study on the amendment of the Hungarian anti-
smoking policy analysed the population health effect of banning
smoking in all closed public places, workplaces and public transport ve-
hicles. Data from the literature, national statistics and surveyswere used
to estimate the effect on disease burden. According to the conservative
model that used 3% discounting and age-weighting, the point estimates
of the long-term annual health gain were close to 1700 attributable
death and 16,000 disability adjusted life years in the Hungarian popula-
tion of 10 million (Ádám et al., 2013).Cross-level issues
A key issue in the assessment of health risks of policies is the quan-
tification of health effects. Quantitative assessment can be perceived as
the quantitative expression of expected changes in health outcome
measures by using numerical information on how a policy affects health
outcomes directly or through induced changes in exposure levels of risk
factors. Quantitative expression of results has advantages to qualitative
description. It is favoured in the decision making process, since it helps
in prioritising themes and considering cost–benefit relations, therefore
it can effectively assist the bargain process. Constructing a logical algo-
rithm from the policy proposal down to health outcomes can help in
the clarification of the quantification process.
However, disadvantages of quantification should also be taken into
consideration when applying such methods for assessment. A single
estimate, even if favourable in decision-making, should not be the
only disseminated result. A point estimate alone cannot reflect the com-
plexity of the issue as well as the uncertainty of estimation. Health ef-
fects cannot be unconditionally added up as this may result in double
counting, therefore the horizontal interrelation between various causal
pathways at different levels should be assessed, too.
Transparency is a universal prerequisite for the description of any as-
sessment processes. Assessors should provide a clear explanation on the
method of information search, evidence evaluation, prioritisation of
health determinants, risk factors and health outcomes, selection of ap-
plied measures and functions, data collection and validity assessment.
An important factor of transparency is the description of uncertainties
in the assessment process, too.
A crucial issue of professional correctness is the acknowledgement
of limitations in the use of methodology. Admitting inability to assess
health outcomes due to lack of data, functions, expert skills, etc., is a pre-
requisite of a transparent process description. Limitations also relate to
the phenomenon of uncertainty. The statement that an outcome cannot
be assessed implies infinite uncertainty.
Uncertainty is a natural attendant of predictions. The assessment of
the impact of a policy, especially when it is prospective projection for
the future, always involves uncertainty. It derives, among others, from
the questionable strength of evidence and validity of data and functions
applied. Numerical information is usually an estimatewith inherited un-
certainty due to randomerror of sampling, and it canbe further enlarged
by the presence of bias and by the extrapolation of information fromone
situation/population to another. Therefore the repeated statement that
uncertainty exists has not much added value; rather its extent should
be described in a qualitative or quantitative way. In the latter case, a
range can be specified that functions as an interval estimate of the result.
More about uncertainties and the way to communicate them could be
found in published literature (Knol et al., 2009; WHO-IPCS, 2008).
Realization of impactmay need time. The description of probable la-
tency of effects is important information in thedecision-making process.
There is a latency period between the planning and implementation
of a policy, as well as a lag phase between policy implementation anddevelopment of health effects. The consideration of health outcomes
dependent on time, i.e. differentiation between short and long term
effects, is a favourable product of an assessment.
To describe and assess strength of evidence on different levels of the
full chain assessment, users are recommended to use guidance on levels
of evidence developed by the National Institute for Health and Clinical
Excellence of the United Kingdom (National Institute for Health and
Clinical Excellence, 2005; Weightman et al., 2005).
Checklist for the integrated assessment of health risks of policies
Themethodological tool, which is a product of consensus discussion
based on individual national case studies, is summarized as a checklist
that can be used together with the guidance for policy health risks
assessment (Table 1). It identifies main issues to be addressed on each
level of the impact chain and provides help on how to conduct
the assessment in broad terms.
Discussion
The Gothenburg consensus paper set the framework and the basic
principles for health impact assessment (WHO, 1988). Since then, expe-
rience has accumulated and demands for the assessment of health
effects of various proposals and initiatives have grown substantially
(Dannenberg et al., 2006, 2008; Veerman et al., 2005). Several guide-
lines have been developed with the aim to unify methodology and aid
users in their efforts to predict impact on health (Abrahams et al.,
2004; Bathia, 2010; Bhatia et al, 2010; Chadderton et al., 2013;
Cole et al., 2005;Harris et al., 2007;Health Canada, 2004;Human Impact
Partners, 2011; Metcalfe et al., 2009; Quigley et al., 2006; Scott-Samuel
et al., 2001; Taylor and Blair-Stevens, 2002). Methods for the quantita-
tive assessment of health outcomes have also been formulated, typically
providing amodel for the characterization of risk factor–health outcome
relation (Boshuizen et al., 2012; Veerman et al., 2005). They either apply
an algorithm to predict risk in an epidemiological approach or use clas-
sical toxicological functions. The latter is typical for the assessment of
health effects related to environmental exposures (Basham, 2001;
Kheirbek et al., 2013; Samoli et al., 2008). Framework for the integrated
quantitative assessment of health risks in environmental health impact
assessment has been developed, too (Briggs, 2008). However, a univer-
sal methodological guideline for the assessment of the complex impact
structure of policies that typically include not only environmental but
also socio-economic determinants of health has been lacking.
The intention of the RAPID project was to formulate a methodologi-
cal tool for those who want to carry out comprehensive assessment
of health risks related to policy proposals. It can be used either as a
standalone tool or within the risk appraisal part of a HIA. Although im-
pact assessment is required within the European Commission as a pre-
paratory action for EC decisions but it discusses health issues rather
rarely. The impact assessment of EU policies is mostly oriented towards
economy, competitiveness and social issues (employment, education).
The presented tool is designed to serve the implementation of the
“Health in all policies” principle on national and international level
alike, as it allows for the comprehensive systematic assessment of
health effects of policies and the identification of the role of relevant
sectors within policy development. To reach the potential users, infor-
mation on the development of the tool was disseminated by the project
website (RAPID, 2013), via a series of workshops at European public
health conferences as well as at national workshops organised for risk
assessors in the time period of 2009–2012.
The most important limitations of the guidance are the lack of
experience from external testing, its “broadness”, and its sensitivity to
cultural issues and understanding of terminology. The guidancewas de-
veloped as a consensus document based on national case studies, the
EU case study and consultation via national workshops. Nevertheless,
experiences from testing the completed guidance on different policy
Table 1
Checklist for the integrated assessment of health risks of policies.
Source: Guliš G., Mekel O., Ádám B. and Cori L., (Eds.), Assessment of population health risks of policies, 2014, Springer; New York. With kind permission of Springer Science + Business Media.
Content of analysis How to do
Policy • Place the policy into international, national, regional or local context
• Describe policy content (main goals, scope, implementation plan, methods of monitoring and evaluation)
• Identify the problem, demand for action, policy actors and ideas
• Identify target population of the policy
• Identify performance and outcome indicators in the policy
• Assess whether timeframe for goals and actions is set
• Consider if cross-analysis across principles, goals and actions could be conducted
• Assess the time course, feasibility and cost of implementation
• List information sources to do the assessment and description
• The policy to be assessed is usually provided by policy-makers
• Read the policy and make a shortlist containing goals, actors, targets, tools, timeframe, implementation
mechanisms and monitoring and evaluation mechanisms
• Seek policy expert opinion if necessary
• Consult authors/stakeholders of the policy
• Consider the entire policy making process in socio-political context
• Consider feasibility of assessment (verifiable objectives, definable target group of the policy, preliminary evidence
for health impact)
Determinants
of health
• Define the applied model of health determinants preferably presenting the holistic model of health
(Lalonde, Dahlgren & Whitehead, etc.), use a pre-set list of health determinants
• Identify which health determinants are influenced by the policy in a transparent way
• Decide upon using a full-scale or limited selection of health determinants for assessment; if limited
selection is used, describe horizontal prioritisation of health determinants, make internal loops of
consideration between the levels of the causal chain in the prioritisation process
• Consider strength of evidence for causality/association/plausibility of the policy impact on determinants,
importance of the related effect (size of population affected, severity of health effects, costs involved),
feasibility of assessment favourably in a quantitative way, demand of policy-makers and extent of
resources available
• Assess interactions between health determinants
• List information sources used to make the assessment and description
• Extensive literature search, use available evidence summaries, reviews
• Use expert opinion — public health and public health policy experts are recommended
• Consult stakeholders
• Use a horizontal prioritisation tool, for example:
o Score each of the following criteria: number of people affected, quality of life affected, related national expenses
and strength of literature evidence from 1 (minimum) to 5 (maximum) for each relevant determinant of health
• Place results into a table, summarize them by determinants and make a ranking
Risk factors • Enlist all influenced risk factors by wider determinants of health
• Prioritise risk factors in a transparent way; make internal loops of consideration between the levels of
the causal chain in the prioritisation process
• Consider strength of evidence (reliability of literature source, biological plausibility, etc.) and significance
of induced health effects (size of exposure change influenced by the policy, size of population affected,
severity of related health outcomes)
• Consider feasibility of quantitative exposure assessment (availability of applicable exposure measures,
numerical information on the baseline level/prevalence of exposure and on the expected change of
exposure related to policy implementation)
• Describe routes of exposure
• Describe exposed population and exposure pattern in different population groups (equity)
• Assess exposure
• Assess interaction between risk factors
• List information sources used to make the assessment and description
• Literature search with focus on epidemiological literature
• Database search (international and national statistics offices, environmental exposure databases, etc.)
• Qualitative assessment by indicating the direction of change or categorically describing its size
• Quantitative assessment by calculating frequency (prevalence) or level (dose, concentration) of exposure
• If direct exposure measures are not available, use proxy measures
• Use a horizontal prioritisation tool, for example:
o Score each of the following criteria: number of people affected, quality of life affected, related national expenses
and strength of literature evidence from 1 (minimum) to 5 (maximum) for each relevant determinant of health
• Place results into a table, summarize them by risk factor and make a ranking
Health
outcomes
• Define influenced health outcomes (apply ICD codes)
• Prioritise health outcomes in a transparent way
• Consider strength of evidence for causality, severity (morbidity, disability andmortality), reversibility and
frequency of occurrence in the population (in short the public health importance)
• Identify populations affected with special attention to susceptible subgroups (equity)
• Consider availability and validity of baseline frequency data of the health condition and of dose/exposure–
response functions applying dose–response coefficients or relative risk estimates
• Assess change in health outcomes
• Determine cost related to health outcome if possible
• Literature search including medical, epidemiological and health economic literature
• Database search (international and national statistics offices, other international, national, regional, local databases)
• Qualitative assessment by indicating the direction of change or by categorically describing the size of effect
• Quantitative assessment by calculating simple frequency measures (morbidity, hospitalization, mortality, etc.)
or measures of disease burden (attributable death, potential years of life lost and disability adjusted life years);
give preference to complex disease burden measures (e.g. disability adjusted life years) if available and feasible
Cross-level
issues
• Consider advantages and disadvantages of quantification (a single estimate may cover the complexity of the issue as well as the uncertainty of estimation, double counting)
• There are likely to be many different full chain pathways within one case; if possible assess interrelations between various causal pathways
• Indicate baseline scenario (what if current trends continue without policy change) at the various levels of the chain
• Acknowledge limitations in the use of methodology
• Describe uncertainty in a qualitative or quantitative way (provide ranges for estimates) at relevant points of the causal pathways as well as the overall uncertainty related to the full chain assessment
• Consider latency period of the realization of health effects, differentiate short and long term effects
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would like to encourage readers to use it and provide feedback. The
broadness of the guidance is given by the topic; policies are usually
complex so should be the guidance for risk assessment. In different
countries public health has different meanings and so do the terms,
such as determinants of health and risk factors which are often used in-
terchangeably. This poses the guidance to a kind of cultural sensitivity,
e.g. terms and steps can be diversely interpreted based on the under-
standing of their meaning.
Despite of the limitations, the broad range of topics addressed to
develop the guidance ensures its wide applicability. The case studies in-
cluded tobacco and energy policy, housing subsidy program, air pollu-
tion legislation, policy on alcohol, wine production, road safety, X-ray
computed tomography use and pandemic influenza interventions.
Details about the case studies can be found in the book by Guliš et al.
(2014) that describes the achievements of the RAPID project.
The comprehensive assessment of health impact of various policies
requires the mapping of the full impact scheme, following each level
of the causal chain from the policy proposal through related health de-
terminants and risk factors to health outcomes. The prioritisation of fac-
tors on each level in a systematic transparent way, the consideration of
evidence and feasibility of assessment including advantages and disad-
vantages of quantification, the assessment of horizontal interactions be-
tween impact pathways, the evaluation of the latency period for the
realization of health effects and the description of uncertainty of esti-
mates are the major issues identified and addressed by our work. The
checklist offers a logical framework that lists up important issues to be
considered during the assessment process and gives advice on imple-
mentation. The guidance provides detailed explanation about the critical
aspects of assessment that helps using the checklist. However, this com-
bined tool is not a cookbook. It is intended to be used by thosewho have
previous experience with risk assessment and HIA, although it can offer
assistance in getting started for those who are new in the field, too.
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